Pages that link to "Q42537997"
Jump to navigation
Jump to search
The following pages link to Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors (Q42537997):
Displaying 50 items.
- The role of early life environmental risk factors in Parkinson disease: what is the evidence? (Q24815642) (← links)
- Neuronal nicotinic receptors in the human brain (Q28141480) (← links)
- Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease (Q28214322) (← links)
- Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice (Q28363006) (← links)
- Nicotinic receptors and Parkinson's disease (Q28377091) (← links)
- Gestational IV nicotine produces elevated brain‐derived neurotrophic factor in the mesocorticolimbic dopamine system of adolescent rat offspring (Q30400631) (← links)
- Regulation by nicotine of Gpr51 and Ntrk2 expression in various rat brain regions (Q30440841) (← links)
- Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra (Q31813959) (← links)
- Chronic nicotine exposure reduces N-methyl-D-aspartate receptor-mediated damage in the hippocampus without altering calcium accumulation or extrusion: evidence of calbindin-D28K overexpression (Q32065508) (← links)
- Nicotine and its interaction with beta-amyloid protein: a short review (Q32077110) (← links)
- Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease (Q32077269) (← links)
- Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist (Q33902026) (← links)
- Cognitive flexibility is associated with KIBRA variant and modulated by recent tobacco use. (Q33967660) (← links)
- Central nicotinic receptors, neurotrophic factors and neuroprotection (Q34002742) (← links)
- Nicotine is a developmental neurotoxicant and neuroprotectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos (Q34292224) (← links)
- Gut feelings about smoking and coffee in Parkinson's disease (Q34416404) (← links)
- Neurocognitive effects of methamphetamine: a critical review and meta-analysis (Q34662295) (← links)
- MPTP: insights into parkinsonian neurodegeneration (Q34802076) (← links)
- Transcriptional regulation by nicotine in dopaminergic neurons (Q34933695) (← links)
- Nicotine's oxidative and antioxidant properties in CNS. (Q34959810) (← links)
- Nicotine and nicotinic receptors; relevance to Parkinson's disease (Q34995021) (← links)
- Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat. (Q35833732) (← links)
- Nicotinic receptor-mediated biphasic effect on neuronal excitability in chick lateral spiriform neurons (Q36094573) (← links)
- Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype? (Q36241219) (← links)
- Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits (Q36316462) (← links)
- Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. (Q36364388) (← links)
- Smoking-Relevant Nicotine Concentration Attenuates the Unfolded Protein Response in Dopaminergic Neurons. (Q36432022) (← links)
- Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms (Q36564840) (← links)
- Population-based prospective study of cigarette smoking and risk of incident essential tremor (Q37195940) (← links)
- Environmental epidemiology of essential tremor (Q37196824) (← links)
- Nicotine and inflammatory neurological disorders (Q37485944) (← links)
- Revisiting the cholinergic hypothesis in the development of Alzheimer's disease (Q37851630) (← links)
- Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease. (Q38193225) (← links)
- Nicotinic acetylcholine receptors on NT2 precursor cells and hNT (NT2-N) neurons (Q40692719) (← links)
- Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in culture (Q40869912) (← links)
- Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors (Q42220091) (← links)
- Presynaptic involvement in the nicotine prevention of the dopamine loss provoked by 6-OHDA administration in the substantia nigra (Q42443783) (← links)
- Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration (Q42493545) (← links)
- Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey. (Q42507674) (← links)
- Tobacco, coffee, and Parkinson's disease (Q42782075) (← links)
- Nicotine dependence and serum BDNF levels in male patients with schizophrenia (Q42957019) (← links)
- An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions (Q43503753) (← links)
- Effects of nicotine on ethanol dependence and brain damage (Q43721053) (← links)
- Nicotine administration reduces striatal MPP+ levels in mice (Q43770932) (← links)
- Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture (Q43860478) (← links)
- Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease (Q44054393) (← links)
- Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice (Q44434726) (← links)
- Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease (Q44701012) (← links)
- Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats. (Q46041518) (← links)
- Exposure of mice to tobacco smoke attenuates the toxic effect of methamphetamine on dopamine systems (Q46170866) (← links)